PortfoliosLab logo

Aridis Pharmaceuticals, Inc. (ARDS)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Aridis Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $242 for a total return of roughly -97.58%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%NovemberDecember2023FebruaryMarch
-97.58%
47.37%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ARDS

Aridis Pharmaceuticals, Inc.

Return

Aridis Pharmaceuticals, Inc. had a return of -73.38% year-to-date (YTD) and -82.55% in the last 12 months. Over the past 10 years, Aridis Pharmaceuticals, Inc. had an annualized return of -55.74%, while the S&P 500 had an annualized return of 8.86%, indicating that Aridis Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-43.91%3.51%
Year-To-Date-73.38%7.03%
6 months-65.10%12.88%
1 year-82.55%-10.71%
5 years (annualized)-55.74%8.86%
10 years (annualized)-55.74%8.86%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-43.22%-16.42%
2022-36.30%11.83%-12.50%29.67%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aridis Pharmaceuticals, Inc. Sharpe ratio is -0.61. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00NovemberDecember2023FebruaryMarch
-0.61
-0.46
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Aridis Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-97.71%
-14.33%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aridis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aridis Pharmaceuticals, Inc. is 97.71%, recorded on Mar 31, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.71%Sep 5, 20181137Mar 31, 2023
-1.47%Aug 31, 20181Aug 31, 20181Sep 4, 20182
-1.15%Aug 15, 20184Aug 20, 20183Aug 23, 20187

Volatility Chart

Current Aridis Pharmaceuticals, Inc. volatility is 100.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%NovemberDecember2023FebruaryMarch
100.61%
15.42%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)